Dublin-based generics company Actavis buys US spec pharma Forest Laboratories for $23.9bn
- Medical Devices
- Controlled Release
- Specialty Pharmaceuticals
- Drug Delivery
- Includes Contract
- Payment Includes Stock
- Payment Includes Cash
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.